dsm-firmenich repurchases 155,456 shares in latest week of €500 million buyback program

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

dsm-firmenich repurchased 155,456 shares between June 29 and July 3, 2026, at an average price of €82.45 per share for a total of €12.8 million. The buyback is part of a €500 million share repurchase program to reduce issued capital, which began on March 12, 2026, alongside a separate €40 million tranche to cover share-based compensation plans that was completed on March 23, 2026. To date, the company has bought back 4,520,418 shares at an average price of €65.86 for a total consideration of €297.7 million. The €500 million capital reduction program is expected to be completed by the end of the third quarter of 2026.

Impact on stocks 1

Synthetic Biology (non-pharma) · 1 stocks
DSM-Firmenich AG
DSFIR
▲ PositiveCapitalrelevance

The company is actively repurchasing shares as part of a €500 million buyback program, which typically signals confidence and supports share price.